The mechanisms of QRQZ on NASH were associated with modulating gut microbiota, thereby inducing the tight junction of gut barrier, reducing the endotoxemia and inhibiting the activation of TLR4/NF-κB signaling pathway in liver (Figure 6). The gene discussed is NFKB1; the disease is serum lipopolysaccharide activity.